Dendritic cell vaccines for the immunocompromised patient: prevention of influenza virus infection
Abstract
Prophylactic vaccination of cancer patients and recipients of hematopoietic stem cell transplant is generally a simple, efficient and cost-effective manner by which to prevent unnecessary infection and enhance overall clinical outcomes. However, some neoplastic conditions, particularly B-cell malignancies, impart a degree of immunosuppression that complicates traditional prophylactic approaches. Here, we make the case that the application of dendritic cell (DC) immunotherapy for the prophylaxis of infectious disease is both appropriate and cost effective for certain niche populations who are at risk of increased morbidity and who respond poorly to traditional vaccination, particularly influenza vaccination. Here we review the full spectrum of our preclinical work in this area, results demonstrating that DCs loaded with subunit recombinant hemagglutinin can generate robust hemagglutinin-specific immune responses both in vitro and in vivo. In vivo data indicated that a single injection of hemagglutinin-loaded DC was sufficient to generate high-titer antibody responses that could mediate protective immunity to lethal influenza virus challenge. The results suggest that DC immunotherapy for influenza prophylaxis is safe and feasible...Continue Reading
References
Citations
Related Concepts
Related Feeds
Blood And Marrow Transplantation
The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.
B-Cell Leukemia (Keystone)
B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.
Cancer Vaccines
Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.